Inicio › Cáncer de próstata › Nueva York

Ensayos clínicos de Cáncer de próstata en Nueva York

123 estudios sobre Cáncer de próstata buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Northwell Health Imbert Cancer Center, Bay Shore
Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills
Northwell Health/Center for Advanced Medicine, Lake Success
y 14 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Yale New Haven Hospital, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT04221542

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Integrated Medical Professionals, New York

Reclutando

Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT06511141

WATER IV PCa (AS Sub-study)

Albany Medical College, Albany
Integrated Medical Professionals, PLLC, New York
University of Rochester Medical Center, Rochester

Reclutando

Edades de 45 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT07650448

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Memorial Sloan Kettering Cancer Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT06141993

A Study of Changes to Prostate Procedures

Memorial Sloan Kettering Suffolk-Commack (Consent only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 5 nov 2026 · NCT06986083

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07114601

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Roswell Park Cancer Institute, Buffalo
Mount Sinai Hospital, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977

A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

Langone Health at NYC University, NYU School of Medicine, New York

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07746713

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
Montefiore Medical Center, The Bronx

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06095089

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07200830

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
y 1 más

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06954337

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Guthrie Cortland Memorial Hospital, Cortland
y 5 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center, Long Island City
Associated Medical Professionals, Syracuse

ReclutandoFase 1/2

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06800313

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

Columbia University Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07319871

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

Associated Medical Professionals, Syracuse

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07832292

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Columbia University Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07082920

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT05751434

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Icahn School of Medicine at Mount Sinai ( Site 0009), New York
Great Lakes Cancer Care ( Site 0047), Williamsville

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Northwell Health R.J. Zuckerberg Cancer Hospital, Lake Success
NYU Langone Health Long Island, Mineola
NYU Langone Health, New York
y 3 más

ReclutandoFase 1

Edades de 18 a 100 · Hombres · Actualizado el 29 oct 2026 · NCT05519449

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

James J. Peters VA Medical Center, Bronx, NY, The Bronx

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 26 oct 2026 · NCT05593497

Precision-Based Genomics in Prostate Cancer

Memorial Sloan Kettering Cancer Center, New York
Mount Sinai Hospital, New York
Weill Cornell Medicine, New York

ReclutandoEstudio observacional

Edades de 18 a 120 · Hombres · Actualizado el 26 oct 2026 · NCT04706663

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Northwell Health Imbert Cancer Center, Bay Shore
New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
Sands Cancer Center, Canandaigua
y 25 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site, New York

ReclutandoFase 1/2

Edades de 18 a 130 · Hombres · Actualizado el 22 oct 2026 · NCT07181161

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 107, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT05914116

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

START New York Long Island, LLC, New Hyde Park
NYU Langone Health, New York
Columbia University Irving Medical Center, New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07103018

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Associated Medical Professionals - Urology ( Site 0081), Syracuse

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

New York Cancer & Blood Specialists, New York
University of Rochester - Wilmot Cancer Institute, Rochester

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06582017

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Hematology Oncology Association of Central New York, East Syracuse
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07213674

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, New Hyde Park
Research Site, New York

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 19 oct 2026 · NCT07611110

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Research Site, New York

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 16 oct 2026 · NCT06879041

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

Research Site, Shirley

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 15 oct 2026 · NCT07711002

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Bassett Medical Center, Cooperstown
Weill Cornell Medicine NY-Presb, New York
University of Rochester Medical Ctr, Rochester
y 2 más

ReclutandoFase 3

Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site, New York

ReclutandoFase 1/2

Edades de 18 a 99 · Hombres · Actualizado el 14 oct 2026 · NCT07590934

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, New York
Research Site, Syracuse

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06952803

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

MSK Commack, Commack
MSKCC-Westchester (500 Westchester Ave.), Harrison
Integrated Medical Professionals, Lake Success
y 10 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.